DK1189900T3 - Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler - Google Patents

Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler

Info

Publication number
DK1189900T3
DK1189900T3 DK00938160T DK00938160T DK1189900T3 DK 1189900 T3 DK1189900 T3 DK 1189900T3 DK 00938160 T DK00938160 T DK 00938160T DK 00938160 T DK00938160 T DK 00938160T DK 1189900 T3 DK1189900 T3 DK 1189900T3
Authority
DK
Denmark
Prior art keywords
melatonergic
drugs
heterocyclic
aminopyrrolidine derivatives
heterocyclic aminopyrrolidine
Prior art date
Application number
DK00938160T
Other languages
Danish (da)
English (en)
Inventor
Katherine S Takaki
Guanglin Luo
Stephen R Bertenshaw
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1189900T3 publication Critical patent/DK1189900T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
DK00938160T 1999-06-30 2000-06-06 Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler DK1189900T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14189499P 1999-06-30 1999-06-30
PCT/US2000/015478 WO2001002392A1 (en) 1999-06-30 2000-06-06 Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Publications (1)

Publication Number Publication Date
DK1189900T3 true DK1189900T3 (da) 2004-04-26

Family

ID=22497702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00938160T DK1189900T3 (da) 1999-06-30 2000-06-06 Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler

Country Status (13)

Country Link
US (1) US6211225B1 (es)
EP (1) EP1189900B1 (es)
JP (2) JP4767463B2 (es)
AT (1) ATE257834T1 (es)
AU (1) AU763963B2 (es)
CA (1) CA2376949C (es)
DE (1) DE60007745T2 (es)
DK (1) DK1189900T3 (es)
ES (1) ES2213022T3 (es)
PE (1) PE20010327A1 (es)
PT (1) PT1189900E (es)
UY (1) UY26226A1 (es)
WO (1) WO2001002392A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
BR0313405A (pt) * 2002-08-12 2005-07-12 Takeda Pharmaceutical Compostos, métodos para preparar um composto e para prevenir e/ou tratar câncer, prodroga, medicamento, modulador do receptor de androgênio, agente para prevenir e/ou tratar hipogonadismo ou pertubação climatérica masculina, osteoporose e câncer, e, uso de um composto
AU2006239942A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
AR055916A1 (es) * 2005-04-22 2007-09-12 Wyeth Corp Derivados de dihidrobenzofurano, usos de los mismos en la preparacion de un medicamento y composicion farmaceutica
BRPI0712014A2 (pt) * 2006-05-22 2011-12-27 Vanda Pharmaceuticals Inc tratamento de distérbios depressivos
JP5289308B2 (ja) * 2007-04-26 2013-09-11 武田薬品工業株式会社 二環性化合物およびその医薬用途
ES2331276B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuestos de fenilpirrolidina.
EP2266975A1 (en) * 2009-06-15 2010-12-29 Ferrer Internacional, S.A. 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR102411809B1 (ko) 2012-01-26 2022-06-22 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
CN105189484B (zh) 2012-11-29 2018-05-04 凯莫森特里克斯股份有限公司 Cxcr7拮抗剂
EP3767297A1 (en) 2012-12-18 2021-01-20 Vanda Pharmaceuticals Inc. Method of determining tau and thereby determining whether a patient has a free-running circadian rhythm
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
MX2021006915A (es) 2018-12-12 2021-08-24 Chemocentryx Inc Inhibidores de cxcr7 para el tratamiento de cancer.
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
US3485835A (en) * 1968-04-10 1969-12-23 Haessle Ab 2-benzoyl-3-tertiaryamino alkoxy benzofuran derivatives
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
BR9708949A (pt) 1996-05-14 1999-08-03 Glaxo Group Ltd Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homem
BR9713690B1 (pt) * 1996-12-10 2009-08-11 agentes melatoninérgicos benzodioxola, benzofurano, diidrobenzofurano e benzodioxano.
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
UY26226A1 (es) 2001-01-31
EP1189900B1 (en) 2004-01-14
JP2003503492A (ja) 2003-01-28
US6211225B1 (en) 2001-04-03
JP5248647B2 (ja) 2013-07-31
PT1189900E (pt) 2004-05-31
AU763963B2 (en) 2003-08-07
JP2011137043A (ja) 2011-07-14
EP1189900A4 (en) 2002-07-31
EP1189900A1 (en) 2002-03-27
ES2213022T3 (es) 2004-08-16
JP4767463B2 (ja) 2011-09-07
ATE257834T1 (de) 2004-01-15
CA2376949C (en) 2009-05-26
WO2001002392A1 (en) 2001-01-11
DE60007745T2 (de) 2005-03-10
CA2376949A1 (en) 2001-01-11
DE60007745D1 (de) 2004-02-19
PE20010327A1 (es) 2001-06-10
AU5324000A (en) 2001-01-22

Similar Documents

Publication Publication Date Title
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
ATE302775T1 (de) Carbolinderivate
DE60119397D1 (de) "2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
HUP0301573A2 (hu) Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE346067T1 (de) Carbolinderivate
DE60121461D1 (de) Kondensierte pyridoindolderivate
PT1349843E (pt) Derivados de tiazolo e de oxazolo como activadores dos receptores activados por proliferadores de peroxissomas humanos
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
SE9702773D0 (sv) Novel compounds
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TR199902848T2 (xx) Ergolin t�revleri ve bunlar�n somatostatin resept�r antagonist olarak kullan�mlar�
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60013486D1 (de) Verbindungen
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
DE60128100D1 (de) Analgetisches arzneimittel
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.